Pomalyst Drug Side Effects Warnings
Pomalyst (pomalidomide) is an immunomodulatory drug prescribed to treat multiple Myeloma (a type of cancer that affects white blood cells)
POMALYST SIDE EFFECTS
The side effects depend on the patient’s previous health history and their particular stage of myeloma. The most common serious side effects that have been observed are:
- Low white blood cell counts
- Low red blood cell counts
- Low platelets (thrombocytopenia)
- Fatigue and weakness
MORE SERIOUS PRMALYST SIDE EFFECTS
Also in the May 2015 MHRA Drug Safety Update included these Pomalyst side effects:
The study stated that heart failure was a common side effect [occurs in between 1/10 and 1/100 patients] who take the drug Pomalyst . In the majority of cases, this side effect occurred in patients with cardiac disease or cardiac risk factors and within six months of beginning treatment with Pomalyst . The MHRA Drug review also concluded that the drug Pomalyst can cause atrial fibrillation, which may trigger sudden heart failure.
Interstitial lung disease (ILD)
The ongoing study also indicated Pomalyst can cause ILD as well as related undesirable effects such as pneumonitis. The study concluded that this side effect is common [occurs in between 1/10 and 1/100 patients who take Pomalyst (pomalidomide)]. The beginning of respiratory symptoms is typically within six months of starting treatment. Yet, there are cases where interstitial lung disease occurred 18 months after starting treatment with the drug Pomalyst.
It is well known that raises alanine aminotransferase and bilirubin levels. The study’s review found that the drug Pomalyst can also cause serious hepatotoxicity, primarily acute hepatitis. Also reports of severe liver failure in patients receiving treatment with the drug Pomalyst; however it could not be conclusively determine if Pomalyst was the only cause of liver failure in these particular cases. The concern for serious hepatic events is the highest in the first 6 months of treatment. Regular liver function monitoring is strongly recommended during this period.
If you are taking Pomalyst (pomalidomide) for treatment of multiple Myeloma and have side effects or concerns, please contact our drug litigation lawyers here or call (800) 486-4450 now.